AbbVie (ABBV) Net Income towards Common Stockholders (QoQ) (2012 - 2026)

AbbVie (ABBV) Net Income towards Common Stockholders (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -61.60%
Dec 31, 2025 865.43%
Sep 30, 2025 -80.02%
Jun 30, 2025 -27.00%
Mar 31, 2025 5,704.35%
Dec 31, 2024 -101.47%
Sep 30, 2024 13.91%
Jun 30, 2024 0.07%
Mar 31, 2024 66.50%
Dec 31, 2023 -53.73%
Sep 30, 2023 -12.14%
Jun 30, 2023 2,189.69%
Mar 31, 2023 -103.92%
Dec 31, 2022 -37.45%
Sep 30, 2022 325.86%
Jun 30, 2022 -79.35%
Mar 31, 2022 11.08%
Dec 31, 2021 27.20%
Sep 30, 2021 327.42%
Jun 30, 2021 -78.94%